Thomas G. Auchincloss, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), bought 2,000 shares at $10.11 ($20K) on 2016-05-12, disclosed to the SEC on 2016-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CNCE | BUY | 2020-02-04 | $11K | — | Filing → |
| CNCE | BUY | 2018-11-19 | $12K | — | Filing → |
| CNCE | BUY | 2018-11-15 | $12K | — | Filing → |